Replies to post #28059 on Marker Therapeutics Inc (MRKR)

[lumpy9200]

or it can be used for earlier stage disease because of absence of toxicity

This point right here is huge IMHO. Absence of toxicity AND reasonable pricing make Multi-TAA a real possibility for use in earlier stage disease. Insane pricing and/or SAE makes the use of virtually everything else a non-starter in early stage cancers.